Search results
Sep 26, 2023 · The theory behind Paxlovid rebound is that the treatment is so effective at suppressing the virus that the immune system does not ramp up its cellular and antibody...
Nov 13, 2023 · A new study by Harvard Medical School researchers at Massachusetts General Hospital and Brigham and Women’s Hospital has found that one in five individuals taking nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19 had a positive test result and shed live potentially contagious virus following an ...
Feb 20, 2024 · What initially was referred to as “Paxlovid rebound”—a return of COVID symptoms or test positivity after starting a course of the antiviral—is now more accurately referred to as “COVID rebound,” because rebound can happen regardless of whether someone takes antivirals.
Mar 25, 2024 · There have been reports of a “rebound” of COVID symptoms in some people within 2 to 8 days after completing the five-day course of Paxlovid; in those cases, some have tested positive again but have no symptoms; others have a recurrence of symptoms.
Dec 13, 2022 · Those who have taken Paxlovid and are concerned about a potential rebound should watch out for returning symptoms in the week or so after they test negative.
May 26, 2022 · Here’s what we know about Paxlovid rebound so far. Why do people even take Paxlovid if their COVID-19 could rebound?
Dec 21, 2023 · CDC examined SARS-CoV-2 rebound studies among patients who did and did not receive antiviral treatment. No consistent association between treatment and rebound was identified. The prevalence of rebound varied, depending upon host factors and the definition of rebound. Rebound symptoms were mild.
